Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume 279, Issue 2, Pages 173-179
Publisher
Wiley
Online
2015-09-10
DOI
10.1111/joim.12411
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Binding of the Long Pentraxin PTX3 to Factor H: Interacting Domains and Function in the Regulation of Complement Activation
- (2014) L. Deban et al. JOURNAL OF IMMUNOLOGY
- Effects of atorvastatin on biomarkers of inflammation in chronic kidney disease
- (2013) Robert G. Fassett et al. CLINICAL NEPHROLOGY
- Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population
- (2013) A. Baragetti et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: Data from the Heart and Soul Study
- (2012) Ruth Dubin et al. AMERICAN HEART JOURNAL
- Pentraxin 3, a Sensitive Early Marker of Hemodialysis-Induced Inflammation
- (2012) Bodil Sjöberg et al. BLOOD PURIFICATION
- Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials
- (2012) Roberto Latini et al. EUROPEAN JOURNAL OF HEART FAILURE
- Interactions of the humoral pattern recognition molecule PTX3 with the complement system
- (2012) Andrea Doni et al. IMMUNOBIOLOGY
- Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
- (2012) Bakhtawar K Mahmoodi et al. LANCET
- Chapter 1: Definition and classification of CKD
- (2012) Kidney International Supplements
- Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
- (2010) P. Stenvinkel JOURNAL OF INTERNAL MEDICINE
- Plasma Pentraxin 3 Concentration Increases in Endurance-Trained Men
- (2010) ASAKO MIYAKI et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis
- (2010) R. Dubin et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Inflammation in End-Stage Renal Disease-What Have We Learned in 10 Years?
- (2010) Juan J. Carrero et al. SEMINARS IN DIALYSIS
- Associations of Pentraxin 3 With Cardiovascular Disease and All-Cause Death
- (2009) Nancy Swords Jenny et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction
- (2009) Shigeru Matsui et al. ATHEROSCLEROSIS
- Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
- (2009) Giuseppe Danilo Norata et al. CIRCULATION
- Effect of Renin Angiotensin System Blockade on Pentraxin 3 Levels in Type-2 Diabetic Patients With Proteinuria
- (2009) M. I. Yilmaz et al. Clinical Journal of the American Society of Nephrology
- Prevalence of blood lipid disturbances in Swedish and foreign-born 60-year-old men and women in Stockholm, Sweden
- (2009) P.E. Wändell et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease
- (2008) M. E. Suliman et al. Clinical Journal of the American Society of Nephrology
- The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality
- (2008) M.E. Suliman et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure
- (2007) Satoshi Suzuki et al. AMERICAN HEART JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started